Txoj Kev Siv thiab Txoj Kev: Kev sib koom tes, kev sib haum xeeb thiab yeej-yeej
cov khoom

Cov khoom

Pitavastatin CAS: 147511-69-1 Chaw tsim tshuaj paus

Pitavastatin yog ib qho inhibitor ntawm HMG-CoA reductase uas catalyzes thawj kauj ruam ntawm cov roj cholesterol synthesis.Nws zoo nkaus li tsw tsw thiab dawb mus rau daj-daj hmoov.Nws yuav siv cov teebmeem los ntawm kev txo cov qib ntawm qee cov khoom muaj roj xws li cov cholesterol hauv lub cev.Yog li ntawd, nws yog feem ntau qhia rau kev kho mob ntawm hypercholesterolemia thiab tiv thaiv kab mob plawv.Nws tsis tuaj yeem txo qis cov roj cholesterol siab thiab triglyceride hauv qee cov neeg mob, tab sis kuj tuaj yeem ua rau cov ntsiab lus siab lipoprotein (HDL), cov qib "zoo" cholesterol.Nws yuav tsum tau muab tshuaj ua ke nrog kev noj zaub mov kom raug.


Product Detail

Khoom cim npe

Kev siv thiab cuam tshuam

Pivastatin yog ib qho tshuaj tiv thaiv hyperlipidemic.Nws tsis yog tsuas yog ib qho tshiab, muaj txiaj ntsig, muaj kev nyab xeeb, thiab tshuaj tua kab mob statin raws li lipid-txo cov tshuaj nrog tus nqi siab tshaj plaws, tab sis kuj muaj zog inhibitor ntawm 3-hydroxy-3-methylglutaryl CoA (HMG-CoA reductase) reductase.Nws tsis tsuas yog muaj kev cuam tshuam zoo ntawm kev txo qis LDL-C thiab TC, tab sis kuj tseem muaj cov noob caj noob ces polymorphism, siab bioavailability, thiab ntev ib nrab-lub neej Thiab tsuas yog ob peb tus neeg mob CYP2C9 metabolism.Siv los kho thawj hyperlipidemia, tsev neeg hypercholesterolemia, thiab sib xyaw lipid. tsis meej pem.

Khoom qauv

336(1)
337(1)

Cov khoom ntim:

338(1)

Cov ntaub ntawv ntxiv:

Kev sib xyaw C25H24FNO4
Assay 99%
Qhov tshwm sim Dawb rau Off-White hmoov
CAS Nr. 147511-69-1
Ntim 25 KG
Txee lub neej 2 xyoo
Cia Khaws rau hauv qhov chaw txias thiab qhuav
Daim ntawv pov thawj ISO.

  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb